
Jia-hai Lee
Examiner (ID: 18800, Phone: (571)270-1691 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658 |
| Total Applications | 603 |
| Issued Applications | 248 |
| Pending Applications | 112 |
| Abandoned Applications | 246 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11092294
[patent_doc_number] => 20160289263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'Synthesis of Cyclic Imide Containing Peptide Products'
[patent_app_type] => utility
[patent_app_number] => 14/778502
[patent_app_country] => US
[patent_app_date] => 2014-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4577
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/778502 | Synthesis of cyclic imide containing peptide products | Mar 18, 2014 | Issued |
Array
(
[id] => 9685490
[patent_doc_number] => 20140242253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'PROCESS FOR SOLUBILIZING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/219561
[patent_app_country] => US
[patent_app_date] => 2014-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 37429
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14219561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/219561 | PROCESS FOR SOLUBILIZING PROTEIN | Mar 18, 2014 | Abandoned |
Array
(
[id] => 10687367
[patent_doc_number] => 20160033513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/773596
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12653
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773596 | Use of CD36 to identify cancer subjects for treatment | Mar 12, 2014 | Issued |
Array
(
[id] => 11249308
[patent_doc_number] => 09474792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides'
[patent_app_type] => utility
[patent_app_number] => 14/772910
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14471
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772910
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772910 | Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides | Mar 12, 2014 | Issued |
Array
(
[id] => 10735981
[patent_doc_number] => 20160082131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'Activatable Membrane-Interacting Peptides and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 14/773240
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26670
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773240
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773240 | Activatable membrane-interacting peptides and methods of use | Mar 12, 2014 | Issued |
Array
(
[id] => 11915410
[patent_doc_number] => 09783586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods'
[patent_app_type] => utility
[patent_app_number] => 14/774478
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 12212
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774478
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774478 | Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods | Mar 10, 2014 | Issued |
Array
(
[id] => 11642207
[patent_doc_number] => 09663563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Aqueous liquid composition'
[patent_app_type] => utility
[patent_app_number] => 14/204618
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11000
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204618
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/204618 | Aqueous liquid composition | Mar 10, 2014 | Issued |
Array
(
[id] => 10676478
[patent_doc_number] => 20160022623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'COMPOSITION AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/773292
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7452
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773292 | COMPOSITION AND USE | Mar 6, 2014 | Abandoned |
Array
(
[id] => 9568754
[patent_doc_number] => 20140186467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN'
[patent_app_type] => utility
[patent_app_number] => 14/197629
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197629
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197629 | COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN | Mar 4, 2014 | Abandoned |
Array
(
[id] => 14085753
[patent_doc_number] => 10238757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Methods and compositions for detection of cancer
[patent_app_type] => utility
[patent_app_number] => 14/188404
[patent_app_country] => US
[patent_app_date] => 2014-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12929
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/188404 | Methods and compositions for detection of cancer | Feb 23, 2014 | Issued |
Array
(
[id] => 10491206
[patent_doc_number] => 20150376228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'PROCESS FOR HIGH EFFICIENCY REFOLDING OF RECOMBINANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/768036
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4305
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768036 | PROCESS FOR HIGH EFFICIENCY REFOLDING OF RECOMBINANT PROTEINS | Feb 20, 2014 | Abandoned |
Array
(
[id] => 9569938
[patent_doc_number] => 20140187651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'MULTI-HIERARCHICAL SELF-ASSEMBLY OF A COLLAGEN MIMETIC PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/176235
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11569
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14176235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/176235 | Multi-hierarchical self-assembly of a collagen mimetic peptide | Feb 9, 2014 | Issued |
Array
(
[id] => 10481916
[patent_doc_number] => 20150366932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'METHODS FOR PRODUCING DIKETOPIPERAZINES AND COMPOSITIONS CONTAINING DIKETOPIPERAZINES'
[patent_app_type] => utility
[patent_app_number] => 14/765018
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14751
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765018
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/765018 | METHODS FOR PRODUCING DIKETOPIPERAZINES AND COMPOSITIONS CONTAINING DIKETOPIPERAZINES | Feb 2, 2014 | Abandoned |
Array
(
[id] => 10670853
[patent_doc_number] => 20160016998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'HIGH-AFFINITY MATRIPTASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/760068
[patent_app_country] => US
[patent_app_date] => 2014-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10287
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760068
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/760068 | HIGH-AFFINITY MATRIPTASE INHIBITORS | Jan 8, 2014 | Abandoned |
Array
(
[id] => 10712733
[patent_doc_number] => 20160058880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'MINIMALLY TOXIC PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/758002
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29012
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758002
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758002 | Minimally toxic prodrugs | Dec 26, 2013 | Issued |
Array
(
[id] => 10468591
[patent_doc_number] => 20150353607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Glycopeptide Compound Or Pharmaceutical Salt Thereof And Method For Preparing Same, And Pharmaceutical Compositions And Applications Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/655830
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9139
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655830
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655830 | Glycopeptide compound or pharmaceutical salt thereof and method for preparing same, and pharmaceutical compositions and applications thereof | Dec 25, 2013 | Issued |
Array
(
[id] => 10946927
[patent_doc_number] => 20140349948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Treatment of Chronic Constipation'
[patent_app_type] => utility
[patent_app_number] => 14/138237
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11117
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138237
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138237 | Treatment of Chronic Constipation | Dec 22, 2013 | Abandoned |
Array
(
[id] => 11872495
[patent_doc_number] => 09744244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Amphipathic peptide'
[patent_app_type] => utility
[patent_app_number] => 14/649606
[patent_app_country] => US
[patent_app_date] => 2013-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 79
[patent_no_of_words] => 22338
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649606
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649606 | Amphipathic peptide | Dec 8, 2013 | Issued |
Array
(
[id] => 11561709
[patent_doc_number] => 09624282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Microdystrophin peptides and methods for treating muscular dystrophy using the same'
[patent_app_type] => utility
[patent_app_number] => 14/091326
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 32
[patent_no_of_words] => 17381
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091326
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091326 | Microdystrophin peptides and methods for treating muscular dystrophy using the same | Nov 25, 2013 | Issued |
Array
(
[id] => 12526923
[patent_doc_number] => 10005817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Peptide pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 14/646246
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 15
[patent_no_of_words] => 61089
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646246
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646246 | Peptide pharmaceuticals | Nov 19, 2013 | Issued |